Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


IADR and AADR applaud the Lancet Oral Health Series.

Moynihan P, Wright JT, Giannobile WV, Ajiboye AS, Fox CH.

Lancet. 2020 Feb 22;395(10224):563-564. doi: 10.1016/S0140-6736(19)33017-X. No abstract available.


Oral Health Effects of Tobacco Products: Science and Regulatory Policy.

Ajiboye AS, Gordon JS, Fox CH, Garcia RI.

J Dent Res. 2019 Oct;98(11):1168-1172. doi: 10.1177/0022034519872946. No abstract available.


American Association for Dental Research Policy Statement on Community Water Fluoridation.

Ajiboye AS, Dawson DR 3rd, Fox CH; AADR Science Information Committee.

J Dent Res. 2018 Nov;97(12):1293-1296. doi: 10.1177/0022034518797274. Epub 2018 Sep 6. No abstract available.


Research and Dental Education: An AADR Perspective on the "Advancing Dental Education: Gies in the 21st Century" Project.

Ferracane JL, Garcia RI, Ajiboye AS, Mullen C, Fox CH.

J Dent Res. 2017 Sep;96(10):1073-1075. doi: 10.1177/0022034517723566. No abstract available.


Androgen Receptor Splice Variants Are Not Substrates of Nonsense-Mediated Decay.

Ajiboye AS, Esopi D, Yegnasubramanian S, Denmeade SR.

Prostate. 2017 Jun;77(8):829-837. doi: 10.1002/pros.23323. Epub 2017 Feb 22.


Assessment of Depression in a Primary Care Setting in Nigeria using the PHQ-9.

Obadeji A, Oluwole LO, Dada MU, Ajiboye AS, Kumolalo BF, Solomon OA.

J Family Med Prim Care. 2015 Jan-Mar;4(1):30-4. doi: 10.4103/2249-4863.152246.


Pattern and predictors of alcohol use disorders in a family practice in Nigeria.

Obadeji A, Oluwole LO, Dada MU, Ajiboye AS.

Indian J Psychol Med. 2015 Jan-Mar;37(1):75-80. doi: 10.4103/0253-7176.150824.


Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.

Schweizer MT, Antonarakis ES, Wang H, Ajiboye AS, Spitz A, Cao H, Luo J, Haffner MC, Yegnasubramanian S, Carducci MA, Eisenberger MA, Isaacs JT, Denmeade SR.

Sci Transl Med. 2015 Jan 7;7(269):269ra2. doi: 10.1126/scitranslmed.3010563.


Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

Antonarakis ES, Heath EI, Smith DC, Rathkopf D, Blackford AL, Danila DC, King S, Frost A, Ajiboye AS, Zhao M, Mendonca J, Kachhap SK, Rudek MA, Carducci MA.

Oncologist. 2013;18(2):163-73. doi: 10.1634/theoncologist.2012-314. Epub 2013 Jan 22.


A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.

Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL.

J Urol. 2010 Jun;183(6):2219-26. doi: 10.1016/j.juro.2010.02.020.

Supplemental Content

Loading ...
Support Center